FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989429071> ?p ?o ?g. }

• W1989429071 endingPage "9" @default.
• W1989429071 startingPage "3" @default.
• W1989429071 abstract "<i>Background:</i> Infliximab, a chimeric anti-tumour necrosis factor monoclonal antibody with potent anti-inflammatory effects, represents an effective treatment option in patients with severe inflammatory bowel disease (IBD). Serious side-effects of such an immunomodulating therapy are speculated and therefore we reviewed our clinical experience in a retrospective safety study looking upon a single cohort of 100 IBD patients from a large German University Hospital. <i>Methods:</i> 100 patients with severe Crohn’s disease (n = 92), ulcerative colitis (n = 7) or indeterminate colitis (n = 1) treated with infliximab (5 mg/kg) from January 2000 to December 2003 were retrospectively analysed for acute and subacute adverse events by chart review. <i>Results:</i> Overall, infliximab therapy was generally well tolerated. No fatal complications, malignancies, autoimmune diseases, neurologic or cardiovascular complications were observed in the cohort during the study period. Overall, adverse events were observed in 10 patients: 2 patients showed an acute infusion reaction, 1 patient a serum sickness-like reaction, in 4 patients a bacterial or viral infection occurred, in 1 patient pancytopenia and 2 patients developed surgical complications. Only 6 patients with adverse events required admission to hospital. A case of tuberculosis after infliximab was not found. The lack of adverse side-effects was associated with young median age and infrequent comorbidities of the cohort. <i>Conclusion:</i> Regarding its strong immunomodulating capacity, infliximab appears to be an efficient and relatively safe therapeutic option for patients with severe IBD. However, the use of infliximab requires careful screening and close patient monitoring to identify patients at risk and the infrequent, but sometimes serious complications of infliximab." @default.
• W1989429071 created "2016-06-24" @default.
• W1989429071 creator A5001985318 @default.
• W1989429071 creator A5055989419 @default.
• W1989429071 creator A5068455274 @default.
• W1989429071 date "2004-01-01" @default.
• W1989429071 modified "2023-09-25" @default.
• W1989429071 title "Safety Aspects of Infliximab in Inflammatory Bowel Disease Patients" @default.
• W1989429071 cites W1982879448 @default.
• W1989429071 cites W1986103102 @default.
• W1989429071 cites W1990943062 @default.
• W1989429071 cites W1995230659 @default.
• W1989429071 cites W1997999969 @default.
• W1989429071 cites W2001681806 @default.
• W1989429071 cites W2006161673 @default.
• W1989429071 cites W2008629972 @default.
• W1989429071 cites W2016436192 @default.
• W1989429071 cites W2020813101 @default.
• W1989429071 cites W2030969940 @default.
• W1989429071 cites W2033057305 @default.
• W1989429071 cites W2038535814 @default.
• W1989429071 cites W2045268327 @default.
• W1989429071 cites W2054001385 @default.
• W1989429071 cites W2061616542 @default.
• W1989429071 cites W2077833843 @default.
• W1989429071 cites W2078385666 @default.
• W1989429071 cites W2078867336 @default.
• W1989429071 cites W2089148416 @default.
• W1989429071 cites W2093521825 @default.
• W1989429071 cites W2103376969 @default.
• W1989429071 cites W2110674268 @default.
• W1989429071 cites W2112264561 @default.
• W1989429071 cites W2127693350 @default.
• W1989429071 cites W2171341132 @default.
• W1989429071 cites W2326330820 @default.
• W1989429071 cites W2335674809 @default.
• W1989429071 cites W2412614937 @default.
• W1989429071 cites W2416188845 @default.
• W1989429071 cites W2682763467 @default.
• W1989429071 cites W3049015163 @default.
• W1989429071 cites W3091264874 @default.
• W1989429071 doi "https://doi.org/10.1159/000080075" @default.
• W1989429071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15297773" @default.
• W1989429071 hasPublicationYear "2004" @default.
• W1989429071 type Work @default.
• W1989429071 sameAs 1989429071 @default.
• W1989429071 citedByCount "54" @default.
• W1989429071 countsByYear W19894290712012 @default.
• W1989429071 countsByYear W19894290712014 @default.
• W1989429071 countsByYear W19894290712015 @default.
• W1989429071 countsByYear W19894290712016 @default.
• W1989429071 countsByYear W19894290712017 @default.
• W1989429071 countsByYear W19894290712020 @default.
• W1989429071 countsByYear W19894290712021 @default.
• W1989429071 crossrefType "journal-article" @default.
• W1989429071 hasAuthorship W1989429071A5001985318 @default.
• W1989429071 hasAuthorship W1989429071A5055989419 @default.
• W1989429071 hasAuthorship W1989429071A5068455274 @default.
• W1989429071 hasBestOaLocation W19894290712 @default.
• W1989429071 hasConcept C126322002 @default.
• W1989429071 hasConcept C141071460 @default.
• W1989429071 hasConcept C167135981 @default.
• W1989429071 hasConcept C197934379 @default.
• W1989429071 hasConcept C2777138892 @default.
• W1989429071 hasConcept C2778260677 @default.
• W1989429071 hasConcept C2779134260 @default.
• W1989429071 hasConcept C2779280984 @default.
• W1989429071 hasConcept C2780479503 @default.
• W1989429071 hasConcept C71924100 @default.
• W1989429071 hasConcept C72563966 @default.
• W1989429071 hasConcept C90924648 @default.
• W1989429071 hasConceptScore W1989429071C126322002 @default.
• W1989429071 hasConceptScore W1989429071C141071460 @default.
• W1989429071 hasConceptScore W1989429071C167135981 @default.
• W1989429071 hasConceptScore W1989429071C197934379 @default.
• W1989429071 hasConceptScore W1989429071C2777138892 @default.
• W1989429071 hasConceptScore W1989429071C2778260677 @default.
• W1989429071 hasConceptScore W1989429071C2779134260 @default.
• W1989429071 hasConceptScore W1989429071C2779280984 @default.
• W1989429071 hasConceptScore W1989429071C2780479503 @default.
• W1989429071 hasConceptScore W1989429071C71924100 @default.
• W1989429071 hasConceptScore W1989429071C72563966 @default.
• W1989429071 hasConceptScore W1989429071C90924648 @default.
• W1989429071 hasIssue "1" @default.
• W1989429071 hasLocation W19894290711 @default.
• W1989429071 hasLocation W19894290712 @default.
• W1989429071 hasLocation W19894290713 @default.
• W1989429071 hasOpenAccess W1989429071 @default.
• W1989429071 hasPrimaryLocation W19894290711 @default.
• W1989429071 hasRelatedWork W2014462309 @default.
• W1989429071 hasRelatedWork W2070285775 @default.
• W1989429071 hasRelatedWork W2122325622 @default.
• W1989429071 hasRelatedWork W2124908533 @default.
• W1989429071 hasRelatedWork W2152817006 @default.
• W1989429071 hasRelatedWork W2258300052 @default.
• W1989429071 hasRelatedWork W2260158034 @default.
• W1989429071 hasRelatedWork W2408939568 @default.
• W1989429071 hasRelatedWork W2418837291 @default.

• next